A study of CD117 expression in dermatofibrosarcoma protuberans and cellular dermatofibroma

Journal of Cutaneous Pathology

Volumn 34, Issue 11, 2007, Pages 857-860

  Labonte, Sebastien ^a   Hanna, Wedad ^a   Bandarchi Chamkhaleh, Bizhan ^a  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 13A; CD34 ANTIGEN; IMATINIB; STEM CELL FACTOR RECEPTOR;

ARTICLE; DERMATOFIBROMA; DERMATOFIBROSARCOMA PROTUBERANS; DISEASE REGISTRY; HUMAN; IMMUNOHISTOCHEMISTRY; INFORMATION RETRIEVAL; PROTEIN EXPRESSION;

ANTIGENS, CD34; DERMATOFIBROSARCOMA; HISTIOCYTOMA, BENIGN FIBROUS; HUMANS; IMMUNOHISTOCHEMISTRY; PROTO-ONCOGENE PROTEINS C-KIT; SKIN NEOPLASMS;

EID: 35348938200     PISSN: 03036987     EISSN: 16000560     Source Type: Journal    
DOI: 10.1111/j.1600-0560.2007.00731.x     Document Type: Article

References (7)

1. Maki RG, Awan RA, Dixon RH, Jhanwar S, Antonescu CR. Differential sensitivity to Imatinib of 2 patients with metastatic sarcoma arising from dermatofibrosarcoma protuberans. Int J Cancer 2002 100: 623.
2. Corless CL, Fletcher JA, Heinrich MC. Biology of gastrointestinal stromal tumors. J Clin Oncol 2004 22: 3813 3825.
3. Sjoblom T, Shimizu A, O'Brien KP, et al. Growth inhibition of dermatofibrosarcoma protuberans tumors by the platelet-derived growth factor receptor antagonist STI571 through induction of apoptosis. Cancer Res 2001 61: 5778.
4. Heinrich MC, McArthur GA, Demetri GD, et al. Clinical and molecular studies of the effect of Imatinib on advanced aggressive fibromatosis (desmoid tumor). J Clin Oncol 2006 24: 1195.
5. Hornick JL, Fletcher CDM. Immunohistochemical staining for KIT (CD117) in soft tissue sarcomas is very limited in distribution. Am J Clin Pathol 2002 117: 188.
6. Sarlomo-Rikala M, Kovatich AJ, Barusevicius A, Miettinen M. CD117: a sensitive marker for gastrointestinal stromal tumors that is more specific than CD34. Mod Pathol 1998 11: 728.
7. Horenstein MG, Prieto VG, Nuckols JD, Burchette JL, Shea CR. Indeterminate fibrohistiocytic lesions of the skin: is there a spectrum between dermatofibroma and dermatofibrosarcoma protuberans? Am J Surg Pathol 2000 24: 996.